O15503 (INSI1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
April 3, 2013.
Version 109.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Insulin-induced gene 1 protein Short name=INSIG-1 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 277 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Mediates feedback control of cholesterol synthesis by controlling SCAP and HMGCR. Functions by blocking the processing of sterol regulatory element-binding proteins (SREBPs). Capable of retaining the SCAP-SREBF2 complex in the ER thus preventing it from escorting SREBPs to the Golgi. Initiates the sterol-mediated ubiquitin-mediated endoplasmic reticulum-associated degradation (ERAD) of HMGCR via recruitment of the reductase to the ubiquitin ligase, AMFR/gp78. May play a role in growth and differentiation of tissues involved in metabolic control. May play a regulatory role during G0/G1 transition of cell growth. Ref.2 Ref.9 Ref.11 Ref.12 Ref.13 |
| Subunit structure | Binds to the SCAP-SREBF2 complex only in the presence of sterols. Interacts with RNF139. Interacts with HMGCR (via its SSD); the interaction, accelerated by sterols, leads to the recruitment of HMGCR to AMFR/gp78 for its ubiquitination by the sterol-mediated ERAD pathway. Interacts with AMFR/gp78 (via its membrane domain); the interaction recruits HMCR at the ER membrane for its ubiquitination and degradation by the sterol-mediated ERAD pathway. Ref.2 Ref.9 Ref.11 Ref.12 Ref.14 |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein Ref.2. |
| Tissue specificity | Expressed in all tissues tested with highest expression in the liver. Ref.2 |
| Induction | By insulin. |
| Post-translational modification | Ubiquitinated. Subsequent to sterol deprivation, the SCAP-SREBF2 complex becomes dissociated from INSIG1, is then ubiquitinated and degraded in proteasomes. Although ubiquitination is required for rapid INSIG1 degradation, it is not required for release of the SCAP-SREBP complex. Ubiquitinated by RNF139. Ref.12 Ref.14 |
| Miscellaneous | Expressed at high levels when nuclear SREBP levels are high as a result of sterol deprivation. |
| Sequence similarities | Belongs to the INSIG family. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CYP2C1 | P00180 | 2 | EBI-6252425,EBI-6251821 | From a different organism. |
| CYP2C2 | P00181 | 3 | EBI-6252425,EBI-4320576 | From a different organism. |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: O15503-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: O15503-2) The sequence of this isoform differs from the canonical sequence as follows: 138-164: AVVGLLYPCIDSHLGEPHKFKREWASV → GIHPQISSIFVLGSLVYFSQEASRWGT 165-277: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 277 | 277 | Insulin-induced gene 1 protein | PRO_0000191675 | |||||
Regions | |||||||||
| Topological domain | 1 – 87 | 87 | Cytoplasmic Ref.10 | ||||||
| Transmembrane | 88 – 108 | 21 | Helical; Potential | ||||||
| Topological domain | 109 – 126 | 18 | Lumenal Potential | ||||||
| Transmembrane | 127 – 147 | 21 | Helical; Potential | ||||||
| Topological domain | 148 – 160 | 13 | Cytoplasmic Ref.10 | ||||||
| Transmembrane | 161 – 177 | 17 | Helical; Potential | ||||||
| Topological domain | 178 – 182 | 5 | Lumenal Potential | ||||||
| Transmembrane | 183 – 203 | 21 | Helical; Potential | ||||||
| Topological domain | 204 – 209 | 6 | Cytoplasmic Ref.10 | ||||||
| Transmembrane | 210 – 230 | 21 | Helical; Potential | ||||||
| Topological domain | 231 – 241 | 11 | Lumenal Potential | ||||||
| Transmembrane | 242 – 262 | 21 | Helical; Potential | ||||||
| Topological domain | 263 – 277 | 15 | Cytoplasmic Ref.10 | ||||||
Amino acid modifications | |||||||||
| Cross-link | 156 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.12 | |||||||
| Cross-link | 158 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.12 | |||||||
Natural variations | |||||||||
| Alternative sequence | 138 – 164 | 27 | AVVGL…EWASV → GIHPQISSIFVLGSLVYFSQ EASRWGT in isoform 2. | VSP_045084 | |||||
| Alternative sequence | 165 – 277 | 113 | Missing in isoform 2. | VSP_045085 | |||||
| Natural variant | 27 | 1 | A → T. Ref.1 Corresponds to variant rs1129825 [ dbSNP | Ensembl ]. | VAR_027683 | |||||
Experimental info | |||||||||
| Mutagenesis | 156 | 1 | K → R: Loss of ubiquitination and degradation. Ref.12 | ||||||
| Mutagenesis | 158 | 1 | K → R: Loss of ubiquitination and degradation. Ref.12 | ||||||
| Mutagenesis | 205 | 1 | D → A: Loss of ability to suppress the cleavage of SREBP2 and to accelerate the degradation of HMGCR. Ref.13 | ||||||
| Sequence conflict | 31 – 32 | 2 | AA → PP in AAB69121. Ref.1 | ||||||
| Sequence conflict | 99 | 1 | A → T in AAB69121. Ref.1 | ||||||
| Sequence conflict | 170 – 172 | 3 | VFV → GFG in AAB69121. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning, human chromosomal assignment, and adipose and hepatic expression of the CL-6/INSIG1 gene." Peng Y., Schwarz E.J., Lazar M.A., Genin A., Spinner N.B., Taub R. Genomics 43:278-284(1997) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT THR-27. |
| [2] | "Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER." Yang T., Espenshade P.J., Wright M.E., Yabe D., Gong Y., Aebersold R., Goldstein J.L., Brown M.S. Cell 110:489-500(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 40-61 AND 64-83, MASS SPECTROMETRY, FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH SCAP AND SREBP2 COMPLEX. |
| [3] | "Cloning of human full-length CDSs in BD Creator(TM) system donor vector." Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A. Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [4] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Placenta. |
| [5] | "High-throughput cloning of full-length human cDNAs directly from cDNA libraries optimized for large and rare transcripts." Birkett C., Cho J., Gau Y., Hamer R., Kelly S., Kovacs K., Liu L., Liu X., Porter J., Sachs A., Shu Y., Sun Z., Wong J., Wu M., Zhang X., Jay G., He W. Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Mammary tumor. |
| [6] | "Human chromosome 7: DNA sequence and biology." Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K., Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R., Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A., Kanematsu E., Gentles S. Tsui L.-C.Science 300:767-772(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Skin. |
| [9] | "Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain." Sever N., Yang T., Brown M.S., Goldstein J.L., DeBose-Boyd R.A. Mol. Cell 11:25-33(2003) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH HMGCR, FUNCTION. |
| [10] | "Membrane topology of human insig-1, a protein regulator of lipid synthesis." Feramisco J.D., Goldstein J.L., Brown M.S. J. Biol. Chem. 279:8487-8496(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TOPOLOGY. |
| [11] | "Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase." Song B.L., Sever N., DeBose-Boyd R.A. Mol. Cell 19:829-840(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH AMFR, FUNCTION. |
| [12] | "Sterol-regulated ubiquitination and degradation of Insig-1 creates a convergent mechanism for feedback control of cholesterol synthesis and uptake." Gong Y., Lee J.N., Lee P.C., Goldstein J.L., Brown M.S., Ye J. Cell Metab. 3:15-24(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH SCAP AND SREBP2 COMPLEX, UBIQUITINATION AT LYS-156 AND LYS-158, MUTAGENESIS OF LYS-156 AND LYS-158. |
| [13] | "Juxtamembranous aspartic acid in Insig-1 and Insig-2 is required for cholesterol homeostasis." Gong Y., Lee J.N., Brown M.S., Goldstein J.L., Ye J. Proc. Natl. Acad. Sci. U.S.A. 103:6154-6159(2006) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASP-205. |
| [14] | "The TRC8 ubiquitin ligase is sterol regulated and interacts with lipid and protein biosynthetic pathways." Lee J.P., Brauweiler A., Rudolph M., Hooper J.E., Drabkin H.A., Gemmill R.M. Mol. Cancer Res. 8:93-106(2010) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RNF139, UBIQUITINATION BY RNF139. |
| + | Additional computationally mapped references. |
Web resources
| Wikipedia Insig1 entry |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | U96876 Genomic DNA. Translation: AAB69121.1. AY112745 mRNA. Translation: AAM44086.1. BT007227 mRNA. Translation: AAP35891.1. AK291675 mRNA. Translation: BAF84364.1. DN996424 mRNA. No translation available. AC144652 Genomic DNA. No translation available. AC231970 Genomic DNA. No translation available. CH236962 Genomic DNA. Translation: EAL23729.1. CH236962 Genomic DNA. Translation: EAL23730.1. CH471149 Genomic DNA. Translation: EAX04529.1. CH471149 Genomic DNA. Translation: EAX04530.1. BC001880 mRNA. Translation: AAH01880.1. |
| IPI | IPI00290111. IPI01015945. |
| RefSeq | NP_005533.2. NM_005542.4. NP_938150.2. NM_198336.2. NP_938151.1. NM_198337.2. |
| UniGene | Hs.520819. |
3D structure databases | |
| ProteinModelPortal | O15503. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O15503. 2 interactions. |
| STRING | 9606.ENSP00000344741. |
PTM databases | |
| PhosphoSite | O15503. |
Proteomic databases | |
| PaxDb | O15503. |
| PRIDE | O15503. |
Protocols and materials databases | |
| DNASU | 3638. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000340368; ENSP00000344741; ENSG00000186480. ENST00000342407; ENSP00000344035; ENSG00000186480. |
| GeneID | 3638. |
| KEGG | hsa:3638. |
| UCSC | uc003wly.3. human. |
Organism-specific databases | |
| CTD | 3638. |
| GeneCards | GC07P155089. |
| HGNC | HGNC:6083. INSIG1. |
| MIM | 602055. gene. |
| neXtProt | NX_O15503. |
| PharmGKB | PA29890. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG263628. |
| HOGENOM | HOG000253021. |
| HOVERGEN | HBG058958. |
| OrthoDB | EOG4JDH7K. |
Enzyme and pathway databases | |
| Reactome | REACT_111217. Metabolism. REACT_147840. SREBP1A/1C/2 is retained in the endoplasmic reticulum by SCAP:cholesterol:INSIG. |
Gene expression databases | |
| ArrayExpress | O15503. |
| Bgee | O15503. |
| CleanEx | HS_INSIG1. |
| Genevestigator | O15503. |
| GermOnline | ENSG00000186480. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR009904. INSIG. IPR025929. INSIG_fam. [Graphical view] |
| PANTHER | PTHR15301. PTHR15301. 1 hit. |
| Pfam | PF07281. INSIG. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| ChiTaRS | INSIG1. human. |
| GenomeRNAi | 3638. |
| NextBio | 14239. |
| SOURCE | Search... |
Entry information
| Entry name | INSI1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O15503 Secondary accession number(s): A4D2N1 Q9BUV5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 7 Human chromosome 7: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
